Rezo Therapeutics
Rezo Therapeutics is a startup headquartered in San Francisco, United States, founded in 2021. It has raised at least $68.1m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Rezo Therapeutics has raised at least $68.1m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Rezo Therapeutics sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in San Francisco
- 3Scan
- 3TA Halo
- Aarki
- Accord Software
- Aeolus Labs
- Aerobotics7
- Agriful Software
- Ai-Coustics
- Aidora
- Aikido Technologies
- Aimerce
Related
- Innovation profile of San Francisco
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Rezo Therapeutics do?
Rezo Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Rezo Therapeutics raised?
At least $68.1m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Rezo Therapeutics based?
Rezo Therapeutics is headquartered in San Francisco, United States.
When was Rezo Therapeutics founded?
Rezo Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.